Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Monash University at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Monash University brings 4 presentations to ASH 2026 in New Orleans. Its program centres on bloodless medicine and red cell biology. Sessions cover transfusion alternatives, and research covers imetelstat's effect on lipids and zanubrutinib in marginal zone lymphoma.

OrganizationASH 2026 Attendance
Monash University
Melbourne, Australia
Universities & research institutes
Public research university in Melbourne, Australia.
Talk
Sat Dec 12
9:30am–10:45am
Blood Management and Transfusion Practice in Patients Who Need Alternatives to Blood
Principles of patient blood management for people who decline transfusion or have rare blood groups or multiple complex antibodies.
Red cells · Patient care
Session
Sat Dec 12
9:30am–10:45am
Optimizing Patient Care: Practicing Bloodless Medicine
Caring for patients who cannot receive blood transfusions, by choice or for lack of compatible blood, in surgery and blood cancer treatment.
Red cells · Patient care
Session
Sun Dec 13
4:30pm–5:45pm
Understanding and Targeting Metabolism in Erythrocyte Development and Disorders
Metabolism drives red blood cell production, and targeting sugar, nucleotide, amino acid, and mitochondrial pathways could fix faulty production in thalassemia.
Red cells · Blood biology

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Monash University

Tell us what you sell and we’ll find the people at Monash University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction